Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
Mitin, Timur, Dr, Hunt, Daniel, PhD, Shipley, William U, Prof, Kaufman, Donald S, Prof, Uzzo, Robert, Prof, Wu, Chin-Lee, MD, Buyyounouski, Mark K, MD, Sandler, Howard, Prof, Zietman, Anthony L, Prof
Published in The lancet oncology (01.08.2013)
Published in The lancet oncology (01.08.2013)
Get full text
Journal Article
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902
Rosenthal, Seth A., MD, Hunt, Daniel, PhD, Sartor, A. Oliver, MD, Pienta, Kenneth J., MD, Gomella, Leonard, MD, Grignon, David, MD, Rajan, Raghu, MD, Kerlin, Kevin J., MD, Jones, Christopher U., MD, Dobelbower, Michael, MD, Shipley, William U., MD, Zeitzer, Kenneth, MD, Hamstra, Daniel A., MD, PhD, Donavanik, Viroon, MD, Rotman, Marvin, MD, Hartford, Alan C., MD, Michalski, Jeffrey, MD, Seider, Michael, MD, Kim, Harold, MD, Kuban, Deborah A., MD, Moughan, Jennifer, MS, Sandler, Howard, MD
Published in International journal of radiation oncology, biology, physics (01.10.2015)
Published in International journal of radiation oncology, biology, physics (01.10.2015)
Get full text
Journal Article